Corinne Cather, PhD

Correlates and Predictors of Criminal Legal Involvement in First-Episode Psychosis

March 30, 2026

More than 10% of people with first-episode psychosis are involved in the legal system before (11%) and while (14%) receiving mental health treatment, which can interrupt access to specialty...

Faith Scanlon, Kim T. Mueser, Corinne Cather

Original Research

Weight Gain and 10-Year Cardiovascular Risk With Sustained Tobacco Abstinence in Smokers With Serious Mental Illness: A Subgroup Analysis of a Randomized Trial

March 23, 2016

A. Eden Evins, Corinne Cather, Eric D. Achtyes, et al

Original Research

Predictors of Early Abstinence in Smokers With Schizophrenia

November 30, 2008

A. Eden Evins, Oliver Freudenreich, Corinne Cather, et al

Original Research

Glucose Metabolism in Patients With Schizophrenia Treated With Olanzapine or Quetiapine: A Frequently Sampled Intravenous Glucose Tolerance Test and Minimal Model Analysis

May 15, 2006

A. Eden Evins, David C. Henderson, Oliver Freudenreich, et al

Original Research

Independent Effects of Tobacco Abstinence and Bupropion on Cognitive Function in Schizophrenia

September 15, 2005

A. Eden Evins, David C. Henderson, Oliver Freudenreich, et al

Original Research

Medical Morbidity and Mortality in Schizophrenia: Guidelines for Psychiatrists

February 15, 2005

A. Eden Evins, David C. Henderson, Oliver Freudenreich, et al

Original Research

Attitudes of Schizophrenia Outpatients Toward Psychiatric Medications: Relationship to Clinical Variables and Insight

October 15, 2004

A. Eden Evins, David C. Henderson, Oliver Freudenreich, et al

Original Research

Two-Year Follow-Up of a Smoking Cessation Trial in Patients With Schizophrenia: Increased Rates of Smoking Cessation and Reduction.

March 1, 2004

A. Eden Evins, David C. Henderson, Oliver Freudenreich, et al

Correlates and Predictors of Criminal Legal Involvement in First-Episode Psychosis

Weight Gain and 10-Year Cardiovascular Risk With Sustained Tobacco Abstinence in Smokers With Serious Mental Illness: A Subgroup Analysis of a Randomized Trial

Predictors of Early Abstinence in Smokers With Schizophrenia

Glucose Metabolism in Patients With Schizophrenia Treated With Olanzapine or Quetiapine: A Frequently Sampled Intravenous Glucose Tolerance Test and Minimal Model Analysis

Independent Effects of Tobacco Abstinence and Bupropion on Cognitive Function in Schizophrenia

Medical Morbidity and Mortality in Schizophrenia: Guidelines for Psychiatrists

Attitudes of Schizophrenia Outpatients Toward Psychiatric Medications: Relationship to Clinical Variables and Insight

Two-Year Follow-Up of a Smoking Cessation Trial in Patients With Schizophrenia: Increased Rates of Smoking Cessation and Reduction.

ELSEWHERE:

FOLLOW US:

Corinne Cather, PhD

Correlates and Predictors of Criminal Legal Involvement in First-Episode Psychosis

Weight Gain and 10-Year Cardiovascular Risk With Sustained Tobacco Abstinence in Smokers With Serious Mental Illness: A Subgroup Analysis of a Randomized Trial

Predictors of Early Abstinence in Smokers With Schizophrenia

Glucose Metabolism in Patients With Schizophrenia Treated With Olanzapine or Quetiapine: A Frequently Sampled Intravenous Glucose Tolerance Test and Minimal Model Analysis

Independent Effects of Tobacco Abstinence and Bupropion on Cognitive Function in Schizophrenia

Medical Morbidity and Mortality in Schizophrenia: Guidelines for Psychiatrists

Attitudes of Schizophrenia Outpatients Toward Psychiatric Medications: Relationship to Clinical Variables and Insight

Two-Year Follow-Up of a Smoking Cessation Trial in Patients With Schizophrenia: Increased Rates of Smoking Cessation and Reduction.

Consensus Report on XT Use in Practice

Subscribe to readmore articles

Subscribe to read
more articles